Prolific Machines

Illuminating biomanufacturing. Enabling tomorrow's biotherapeutics.

Prolific Machines was founded in 2020, is headquartered in San Francisco, United States, lists 11–50 employees, and has $97.0M in recorded funding across 4 rounds.

Employees
11–50
Founded
2020
Business Model
B2B
Total Funding
$97.0M
Last Round
$55.0M Series BJun 2024
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 4 investors for this company. The full record is or through the API.

About

Prolific Machines is a biotechnology company pioneering optogenetic cell line development and AI-driven bioprocess optimization for biopharmaceutical manufacturing. The company's Photomolecular platform uses light to precisely control gene expression in mammalian cell lines, enabling up to 5-fold increases in therapeutic protein titers and unlocking production of difficult-to-express biotherapeutics including antibodies, biosimilars, and multispecific proteins. By decoupling cell growth from protein production through light-mediated control, Prolific addresses key challenges in biomanufacturing cost, consistency, and scalability. The platform is cell-line agnostic and adaptable to any bioreactor, positioning it as an infrastructure layer for next-generation biologics production.

Summary

Prolific Machines is a Biotech company based in San Francisco, United States, founded in 2020. It lists 11–50 employees. It has raised $97.0M in total across 4 rounds, most recently a $55.0M Series B round in Jun 2024. Investors include Mayfield Fund, Breakthrough Energy Ventures and Ki Tua Fund.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries B1Jun 2024
$55.0M

Sign up to see all 4 events

Funding: Pre-Seed through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
CertaraIPO

Global biosimulation software and services company accelerating drug development for 2,000+ bioph...

Radnor, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$1.3BDec 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Prolific Machines on Indexed.vc
<a href="https://indexed.vc/companies/prolific-machines"><img src="https://indexed.vc/api/badge/company/prolific-machines" alt="Prolific Machines on Indexed.vc" width="260" height="76" /></a>